← Back to Search
Citrullination: A Target For Disease Intervention In Multiple Sclerosis And Other Inflammatory Diseases?
R. G. Chirivi, J. W. V. Rosmalen, G. Jenniskens, G. Pruijn, J. Raats
Published 2013 · Medicine
Download PDFAnalyze on Scholarcy
Citrullinated histone epitopes are involved in the very early stages of inflammatory responses. An important early event is the activation of neutrophils. It has been shown that Peptidyl Arginine Deiminase (PAD) expression levels increase upon pro-inflammatory signalling followed by activation of neutrophils. Subsequently, PAD enzymes cause histone citrullination in the activated neutrophils. Histone citrullination is involved in various processes. One of the most important is NETosis, which results in the release of citrullinated histones to the extracellular space. There, they are involved in Neutrophil Extracellular Trap (NET) formation, which intensifies the inflammatory response. The central role of citrullinated histones in early inflammation makes NETs an attractive target for inflammatory disease intervention. Moreover, the safety profile is expected to be superior to immune-suppressing biologicals, like anti- Tumour Necrosis Factor (TNF) drugs. It is anticipated that shielding citrullinated histone epitopes from the immune system, as well as interfering with their putative roles in the inflammatory response, will have a broad applicability in preventing and treating various inflammatory diseases, including multiple sclerosis.
This paper references
Anti-Citrullinated Protein Antibodies as Novel Therapeutic Drugs in Rheumatoid Arthritis
R. G. Chirivi (2013)
Novel small molecule protein arginine deiminase 4 (PAD4) inhibitors.
M. Bozdag (2013)
Opposition between PKC isoforms regulates histone deimination and neutrophil extracellular chromatin release
Indira Neeli (2013)
Epigenetic changes in patients with multiple sclerosis
M. Koch (2013)
NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis
R. Khandpur (2013)
Inhibiting citrullination in rheumatoid arthritis: taking fuel from the fire
B. Fisher (2012)
Specific expression of PAD4 and citrullinated proteins in lung cancer is not associated with anti-CCP antibody production.
Z. Baka (2011)
ePAD, an oocyte and early embryo-abundant peptidylarginine deiminase-like protein that localizes to egg cytoplasmic sheets.
P. Wright (2003)
Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
X. Zhao (2008)
Peptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities.
Ola Kilsgård (2012)
Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation.
C. Foulquier (2007)
Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor.
A. Chumanevich (2011)
Neutrophil Extracellular Traps Kill Bacteria
V. Brinkmann (2004)
D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.
Kevin L Bicker (2012)
Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis
M. Moscarello (2013)
Regulation of protein Citrullination through p53/PADI4 network in DNA damage response.
Chizu Tanikawa (2009)
Novel inhibitors of protein arginine deiminase with potential activity in multiple sclerosis animal model.
Lianhu Wei (2013)
Citrullination under physiological and pathological conditions.
Z. Baka (2012)
Functional Connection between Deimination and Deacetylation of Histones
H. Denis (2009)
Methylation-dependent PAD2 upregulation in multiple sclerosis peripheral blood
R. Calabrese (2012)
of haematopoietic cells
H Yao (2008)
Increased Citrullination of Histone H3 in Multiple Sclerosis Brain and Animal Models of Demyelination: A Role for Tumor Necrosis Factor-Induced Peptidylarginine Deiminase 4 Translocation
F. Mastronardi (2006)
Citrullination of Inhibitor of Growth 4 (ING4) by Peptidylarginine Deminase 4 (PAD4) Disrupts the Interaction between ING4 and p53*
Q. Guo (2011)
Citrullination of CXCL12 Differentially Reduces CXCR4 and CXCR7 Binding with Loss of Inflammatory and Anti-HIV-1 Activity via CXCR41
S. Struyf (2009)
Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system
Abdiwahab A. Musse (2008)
Knotting the NETs: Analyzing histone modifications in neutrophil extracellular traps
Indira Neeli (2012)
Histone Arg Modifications and p53 Regulate the Expression of OKL38, a Mediator of Apoptosis*
H. Yao (2008)
R Khandpur (2013)
Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis
E. Vossenaar (2004)
Pathways to gene identification in rheumatoid arthritis: PTPN22 and beyond
P. Gregersen (2005)
Acute multiple sclerosis (marburg type) is associated with developmentally immature myelin basic protein
D. D. Wood (1996)
Citrullination: a posttranslational modification in health and disease.
B. György (2006)
Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis
D. Makrygiannakis (2012)
Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice
R. Raijmakers (2006)
The Role of Citrullinated Proteins Suggests a Novel Mechanism in the Pathogenesis of Multiple Sclerosis
M. Moscarello (2006)
Sequential reorganization of cornified cell keratin filaments involving filaggrin-mediated compaction and keratin 1 deimination.
A. Ishida-Yamamoto (2002)
Human PAD4 Regulates Histone Arginine Methylation Levels via Demethylimination
Y. Wang (2004)
Protein arginine deiminase 4: a target for an epigenetic cancer therapy
J. L. Slack (2010)
Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis
Natalia Wegner (2010)
Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells
G.-y. Liu (2006)
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.
P. Gregersen (1987)
Citrullination of CXCL8 increases this chemokine’s ability to mobilize neutrophils into the blood circulation
Tamara Loos (2009)
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation
P. Proost (2008)
cDNA cloning, gene organization and expression analysis of human peptidylarginine deiminase type I.
M. Guerrin (2003)
Myelin in multiple sclerosis is developmentally immature.
M. Moscarello (1994)
Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated
F. Mastronardi (2007)
Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis.
Andrew J Kinloch (2008)
Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase.
K. Lundberg (2008)
The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the α- and β-Chains of Fibrin1
C. Masson-Bessière (2001)
Role for peptidylarginine deiminase enzymes in disease and female reproduction.
Sachi Horibata (2012)
Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
Natalia Wegner (2010)
Anti-citrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease?
V. Ruíz-Esquide (2012)
Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors.
J. Jones (2012)
Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation
G. Alenius (2006)
Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration
H. Asaga (2001)
Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation
Y. Wang (2009)
PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps
Pingxin Li (2010)
Potential Role of Peptidylarginine Deiminase Enzymes and Protein Citrullination in Cancer Pathogenesis
Sunish Mohanan (2012)
Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies
C. Liu (2012)
N-α-Benzoyl-N5-(2-Chloro-1-Iminoethyl)-l-Ornithine Amide, a Protein Arginine Deiminase Inhibitor, Reduces the Severity of Murine Collagen-Induced Arthritis
V. Willis (2011)
Peptidylarginine Deiminase 2 Suppresses Inhibitory κB Kinase Activity in Lipopolysaccharide-stimulated RAW 264.7 Macrophages*
H. Lee (2010)
Rheumatoid arthritis and periodontal disease.
J. Berthelot (2010)
Deimination of myelin basic protein
L. Pritzker (2000)
Potential Role for Peptidylarginine Deiminase 2 (PAD2) in Citrullination of Canine Mammary Epithelial Cell Histones
B. Cherrington (2010)
JCCI, an open access journal Multiple Sclerosis mediated compaction and keratin 1 deimination
Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression
P. Li (2010)
Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease.
Nimish K. Acharya (2012)
Effect of citrullination on the function and conformation of antithrombin
A. Ordóñez (2009)
Discovery of a new class of inhibitors for the protein arginine deiminase type 4 (PAD4) by structure-based virtual screening
C. Teo (2012)
Peptidylarginine deiminase of the hair follicle: characterization, localization, and function in keratinizing tissues.
G. Rogers (1997)
PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures
Marc Leshner (2012)
Rheumatoid arthritis and smoking: putting the pieces together
Z. Baka (2009)
Increased PADI4 expression in blood and tissues of patients with malignant tumors
X. Chang (2008)
Estrogen-enhanced peptidylarginine deiminase type IV gene (PADI4) expression in MCF-7 cells is mediated by estrogen receptor-alpha-promoted transfactors activator protein-1, nuclear factor-Y, and Sp1.
S. Dong (2007)
Deimination and expression of peptidylarginine deiminases during cutaneous wound healing in mice.
F. Coudane (2011)
Subcellular Localization of Peptidylarginine Deiminase 2 and Citrullinated Proteins in Brains of Scrapie-Infected Mice: Nuclear Localization of PAD2 and Membrane Fraction-Enriched Citrullinated Proteins
B. Jang (2011)
A novel superfamily of enzymes that catalyze the modification of guanidino groups.
H. Shirai (2001)
Regulation of p53 Target Gene Expression by Peptidylarginine Deiminase 4
Pingxin Li (2008)
Histone citrullination by protein arginine deiminase: is arginine methylation a green light or a roadblock?
P. Thompson (2006)
Anticitrullinated peptide antibodies in the serum of heavy smokers without rheumatoid arthritis. A differential effect of chronic obstructive pulmonary disease
V Ruiz-Esquide (2012)
The development of N-α-(2-carboxyl)benzoyl-N(5)-(2-fluoro-1-iminoethyl)-l-ornithine amide (o-F-amidine) and N-α-(2-carboxyl)benzoyl-N(5)-(2-chloro-1-iminoethyl)-l-ornithine amide (o-Cl-amidine) as second generation protein arginine deiminase (PAD) inhibitors.
C. Causey (2011)
NET balancing: a problem in inflammatory lung diseases
O. Cheng (2013)
PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease
E. Vossenaar (2003)
Citrullination is an inflammation-dependent process.
D. Makrygiannakis (2006)
Citrullination of linear and cyclic altered peptide ligands from myelin basic protein (MBP(87-99)) epitope elicits a Th1 polarized response by T cells isolated from multiple sclerosis patients: implications in triggering disease.
George Deraos (2008)
Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain
H. Asaga (2002)
Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D.
L. Pritzker (2000)
Nuclear Localization of Peptidylarginine Deiminase V and Histone Deimination in Granulocytes*
K. Nakashima (2002)
Expression of peptidylarginine deiminase type 4 (PAD4) in various tumors
X. Chang (2006)
This paper is referenced by
The emerging potential for epigenetic therapeutics in noncancer disorders
C. Bell (2016)
Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options
N. Gudmann (2015)
Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis.
B. A. '. Hart (2019)
Multiple Sclerosis and Experimental Allergic Encephalomyelitis.
K. Pahan (2013)
Citrullination Following Traumatic Brain Injury: A Mechanism for Ongoing Pathology Through Protein Modification
Rachel C. Lazarus (2017)
Progress in the Chemistry of Organic Natural Products 106
A. Kinghorn (2017)
In silico targeting PAD4 for the treatment of rheumatoid arthritis
M. Soni (2019)
Filifactor alocis: The Newly Discovered Kid on the Block with Special Talents
W. Aruni (2014)
Noncovalent Protein Arginine Deiminase (PAD) Inhibitors Are Efficacious in Animal Models of Multiple Sclerosis.
Elizabeth J Curiel Tejeda (2017)
Autoimmune encephalomyelitis Model
Bert A.’t Hart (2017)
Potential of epigenetic therapies in non-cancerous conditions
Theresa Mau (2014)
Multiple Sclerosis Diagnosis by Flow Cytometry
Vijay Kumar Kurna (2015)
Expanding Antigen-specific Tr1 Cells to Treat Autoimmunity
P. Ambalavanan (2015)
Experimental autoimmune encephalomyelitis in the common marmoset: a translationally relevant model for the cause and course of multiple sclerosis
B. '. ’t Hart (2019)
An essential role of virus-infected B cells in the marmoset experimental autoimmune encephalomyelitis model
B. T. ’t Hart (2017)
Biologics and Immunologics related to Rheumatoid Arthritis
Dipika Rungta (2015)
Human Deiminases: Isoforms, Substrate Specificities, Kinetics, and Detection.
Bushra K. Amin (2017)
The Protein Arginine Deiminases: Inhibitors and Characteristics
Curiel Tejeda (2015)
An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders
Mohammed I. Alghamdi (2019)
Effects of chromatin remodelling on neutrophil gene expression
F. A. Makki (2017)
A structural and computational study of citrulline in biochemical reactions
Alessio Caruso (2017)
Brain Citrullination Patterns and T Cell Reactivity of Cerebrospinal Fluid-Derived CD4+ T Cells in Multiple Sclerosis
Wolfgang Faigle (2019)
A B Cell-Driven Autoimmune Pathway Leading to Pathological Hallmarks of Progressive Multiple Sclerosis in the Marmoset Experimental Autoimmune Encephalomyelitis Model
B. '. ’t Hart (2017)
Investigating the tumourigenic aspects of the bone marrow microenvironment in multiple myeloma
Bessie Anne Ellis (2014)
Citrullinated Glucose-Regulated Protein 78 Is an Autoantigen in Type 1 Diabetes
D. Rondas (2014)
Therapeutic ACPA inhibits NET formation: a potential therapy for neutrophil-mediated inflammatory diseases
Renato G. S. Chirivi (2020)
Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes
Timothy Travers (2016)
Neuronal and vascular deficits following chronic adaptation to high altitude
N. Cramer (2018)
IN VIVO STUDIES OF CELL-FREE DNA AND DNASE IN A MURINE MODEL OF POLYMICROBIAL SEPSIS
S. Mai (2016)
Molecular Interplay between the Dimer Interface and the Substrate-Binding Site of Human Peptidylarginine Deiminase 4
Chien-Yun Lee (2017)
Protein Citrullination: A Proposed Mechanism for Pathology in Traumatic Brain Injury
Rachel C. Lazarus (2015)